Antiviral activity of silymarin in comparison with baicalein against EV-A71.
Salima S LalaniMohd Ishtiaq AnasirChit Laa PohPublished in: BMC complementary medicine and therapies (2020)
Silymarin has a stronger inhibition activity against EV-A71 in comparison to baicalein. It could serve as a promising antiviral drug to treat EV-A71 infections.
Keyphrases